BioSpace News Archive

BioRestorative Therapies, Inc . today announced that Northwell Health, New York State’s largest health care provider has been activated and can now start recruitment in the State of New York for BioRestorative’s ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (“cLDD”).

Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to form two-dimensional nanosheets like graphene.

Intelligent Bio Solutions Inc. today announced the successful completion of a key development milestone in its plans to add ketamine and tramadol to its Intelligent Fingerprinting Drug Screening System.

Sirtex Medical (“Sirtex”) announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a Sweden-based contract development and manufacturing organization as well as Degradable Starch Microspheres (DSM) sales and marketing company.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company’s strategy, performance and the latest market developments and trends during a fireside chat at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023.

OrthoCarolina and healthPrecision announced today the formation of a strategic partnership to bring Medical Brain®, a state-of-the-art AI platform that delivers real-time, high-precision patient-centric care, to OrthoCarolina’s vast network of over 300 providers at nearly 40 locations across the Southeast.

Sparta Biomedical, a privately held medical device company specializing in partial knee resurfacing, is excited to announce Dr. Adam Yanke’s presentation at the 2023 ICRS World Congress in Barcelona, Spain.

Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”) today announced that it will be presenting at the H.C. Wainwright 25th Annual Global Investment Conference, being held in person and virtually from September 11-13, 2023.

Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, announced company management will be participating in the following investor conferences.

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY, on Wednesday, September 13, 2023, which includes a presentation beginning at 2:55 pm ET.